“2025年是诺诚健华发展进程的第十年,我在创办诺诚健华以来遇到的困难是我前面所有职业生涯加起来的总和。” 说这句话的,是诺诚健华联合创始人、董事长兼CEO崔霁松。在男性占比更高的商业世界,她是性别上的“少数”,但在技术日新月异的医药行业,崔霁松的职业生涯从Merck书写至BioDuro,再到自立门户加入国产创新药自研浪潮,其已是行业佼佼者。 3月7日,“三八”国际妇女节前夕,崔霁松接受了《...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.